{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-006945","form_type":"8-K","ticker":"GTHP","cik":"0000924515","company_name":"GUIDED THERAPEUTICS INC","filed_at":"2022-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.666979+00:00","generated_at":"2026-06-23T09:35:56.922027+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Guided Therapeutics closes $3.3M bridge financing, exchanges Auctus debt, targets FDA study completion","bullets":["Raised ~$3.3M via 6.6M shares at $0.50 each, plus four-year warrants for 6.6M shares at $0.50 and 6.6M at $0.65.","Auctus exchanged $1.06M debt and 8.78M warrants for $1.95M in units (3.9M shares, 3.9M warrants at $0.50 and $0.65); residual $490K debt over 18 months.","Net proceeds ~$3.2M; primary use to fund clinical study data for FDA approval of LuViva Advanced Cervical Scan, also support international sales and reduce debt.","Stockholders' equity nearly break-even; Company to withdraw S-1/A for Nasdaq uplist and reapply when market conditions improve.","Investors include board members Richard Blumberg, Michael James, John Imhoff."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-006945","json":"https://secwatch.observer/filing/0001477932-22-006945.json","markdown":"https://secwatch.observer/filing/0001477932-22-006945.md","text":"https://secwatch.observer/filing/0001477932-22-006945.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/924515/000147793222006945/0001477932-22-006945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/924515/000147793222006945/gthp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T09:35:56.922027+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}